Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Diabetes Mellitus, Insulin-Dependent, 12 × Radiation × 1 year × Clear all

Sponsor

Conditions

Prostatic Neoplasms 28 Glioblastoma 26 Breast Neoplasms 19 Lung Neoplasms 18 Carcinoma, Non-Small-Cell Lung 14 Oropharyngeal Neoplasms 12 Squamous Cell Carcinoma of Head and Neck 10 Gliosarcoma 9 Brain Neoplasms 9 Uterine Cervical Neoplasms 8 Urinary Bladder Neoplasms 8 Sarcoma 7 Melanoma 7 Esophageal Neoplasms 7 Astrocytoma 7 Triple Negative Breast Neoplasms 6 Mouth Neoplasms 6 Head and Neck Neoplasms 6 Glioma 6 Rectal Neoplasms 5 Pancreatic Neoplasms 5 Neoplasm Metastasis 5 Carcinoma, Squamous Cell 5 Adenocarcinoma Of Esophagus 5 Neoplasms 4 Laryngeal Neoplasms 4 Esophageal Squamous Cell Carcinoma 4 Carcinoma, Hepatocellular 4 Carcinoma 4 Adenocarcinoma of Lung 4

Interventions

tremelimumab 4 lenvatinib 3 durvalumab 3 Nivolumab 3 Ipilimumab 2 spartalizumab 1 relatlimab 1 poly ICLC 1 pembrolizumab 1 balstilimab 1 Radiotherapy 1 Peptides 1 Opdualag 1 Capecitabine 1 Bevacizumab 1 Axitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡